Invention Grant
- Patent Title: Treatment of mucositis with kallikrein inhibitors
- Patent Title (中): 用激肽释放酶抑制剂治疗粘膜炎
-
Application No.: US12683094Application Date: 2010-01-06
-
Publication No.: US08637454B2Publication Date: 2014-01-28
- Inventor: Andrew Sternlicht
- Applicant: Andrew Sternlicht
- Applicant Address: US MA Cambridge
- Assignee: Dyax Corp.
- Current Assignee: Dyax Corp.
- Current Assignee Address: US MA Cambridge
- Agency: Foley & Lardner LLP
- Agent Michel Morency; Shelby J. Walker
- Main IPC: A61K38/00
- IPC: A61K38/00

Abstract:
Methods, kits and compositions are disclosed that include an isolated kallikrein inhibitor for the treatment of mucositis.
Public/Granted literature
- US20100183625A1 Treatment of Mucositis with Kallikrein Inhibitors Public/Granted day:2010-07-22
Information query
IPC分类: